The first xenograft studies demonstrating that HSCs are functional disease-initiating cells in MDS were performed by Pang et al., when they transplanted purified HSCs (LIN-CD34+CD38-CD45RA-CD90+) from MDS samples into immunodeficient mice (Pang et al., 2013). Here, CD38 is linked to myelodysplastic syndrome.